Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer, Drug Design Development and Therapy, June 2015, Dove Medical Press,
DOI: 10.2147/dddt.s82724.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page